Skip to main content

Table 1 Epidemiological data about the 65 patients from Belgium and Luxembourg.

From: Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: Analysis of the HIV-2 Belgium and Luxembourg database

Gender

Female

31 (48.5%)

 

Male

33 (51.5%)

 

Unknown

1

Age

Mean

42.84 years (range from 25 to 71)

 

Median

42 years

Countries of origin

West Africa

29 (63%)

 

   Ghana

8

 

   Ivory Coast

7

 

   Cape Verde Islands

5

 

   Guinea-Bissau

3

 

   Guinea

2

 

   Senegal

1

 

   Liberia

1

 

   Nigeria

1

 

   Burkina-Faso

1

 

Europe

11 (24%)

 

   Belgium

6

 

   Portugal

5

 

Central and Southern Africa

4 (8.5%)

 

   Democratic Republic Congo

3

 

   South-Africa

1

 

Asia: Nepal

2 (4%)

 

Not documented

19

Transmission

Heterosexual

37 (86%)

 

Homosexual (MSM)

2 (4.5%)

 

Intra-venous drug use

2 (4.5%)

 

Transfusion

2 (4.5%)

 

Not documented

22

Year of infection

Between 2002 and 2006

10 (33%)

 

Between 1997 and 2001

7 (23%)

 

Before 1997

13 (43%)

 

Not documented

22

ARV use

Treated

20 (31%)

 

   Exposed to NRTIs only

5

 

   Exposed to NRTIs and PIs

15

 

   Treated at the end of 2006

15

 

Never been treated

45 (69%)

Subtype

A

25 (83%)

 

B

5 (17%)

 

Not documented

35

  1. The percentages were calculated for patients with available data (collected until 2006-12-31). ARV: antiretroviral therapy